Scientists hunt for genetic roots of rare childhood blood disorder

NCT ID NCT03912129

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study investigates the genetic causes of pediatric Evans syndrome, a rare autoimmune condition where the immune system attacks blood cells. Researchers analyze blood samples from affected children and their families to find known or new mutations. The goal is to better understand the disease's biology and classify patients by their genetic and immune profiles.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify specific genes responsible for pediatric Evans syndrome, potentially pointing toward targeted treatments or better management strategies.
What could go wrong: This is an observational study, not a treatment trial. It may not find clear genetic causes, and any discoveries would need further research before leading to therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EVANS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Evans syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EVANS SYNDROME

Contacts and locations

Show contact details

Locations

CHU de Bordeaux

Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.